Article Sidebar

Published: 2026-04-25
Abstract Views: 0
DOI: https://doi.org/10.52163/yhc.v67i4.4893
Issue
Tập 67 Số 4
Section
Articles
How to Cite
Dương, N. T. Ánh, Hương, P. T. T., Nam, N. V., Sơn, N. H., Hương, N. T. M., & Nhật, N. Q. (2026). ORAL MUCOSITIS IN PATIENTS WITH ACUTE LEUKEMIA UNDERGOING CHEMOTHERAPY AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION. Vietnam Journal of Community Medicine, 67(4). https://doi.org/10.52163/yhc.v67i4.4893

ORAL MUCOSITIS IN PATIENTS WITH ACUTE LEUKEMIA UNDERGOING CHEMOTHERAPY AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION

Nguyen Thi Anh Duong1, Pham Thi Thu Huong2, Nguyen Van Nam1, Nguyen Hong Son1, Nguyen Thi Mai Huong1, Nguyen Quoc Nhat1
1 National Institute of Hematology and Blood Transfusion
2 Phenikaa University

Main Article Content

Abstract

Objective: To describe the characteristics and prevalence of oral mucositis (OM) in patients with acute leukemia undergoing chemotherapy at the National Institute of Hematology and Blood Transfusion.


Methods: A cross-sectional descriptive study was conducted on 301 patients with AL who underwent chemotherapy from January to May 2025. All patients were assessed on day 10 after chemotherapy initiation. The severity of oral mucositis was assessed using the WHO scale.


Results: Overall OM incidence was 62,5% (188/301). WHO grades: grade 1, 39,5% (119); grade 2, 20,6% (62); grade 3, 2,3% (7); no grade 4. Most affected sites: buccal mucosa (26,9%), lips (16.9%), tongue (14,0%), palate (13,6%). On day 10, 49,2% had ANC ≤0,5 G/L and 16,9% had platelets ≤20 G/L. Oral hygiene: 87,4% brushed ≥2 times/day; 56,5% performed mucosal cleaning; 0.9% NaCl was most used rinse (39,5%).


Conclusion: OM is common in acute leukemia patients receiving chemotherapy, predominantly mild to moderate. Routine oral care, safe mouth-rinse guidance, and close monitoring during neutropenia are essential to prevent and mitigate OM.

Article Details

Keywords

Acute leukemia, chemotherapy, oral mucositis, nursing care.

References

1. Lu K. WHO Mucositis Scale. September 29, 2022. Accessed August 21, 2024. https://www.otoscape.com/eponyms/who-mucositis-scale.html
2. Öhrn KEO, Sjödén PO. Experiences of oral care in patients with haematological malignancies or head and neck cancer: Experiences of oral care. European Journal of Cancer Care. 2003;12(3):274-282. doi:10.1046/j.1365-2354.2003.00417.x
3. Song J, Yu H, Ryu E. Comparative Analysis of Chemotherapy-Induced Oral Mucositis, Nutritional Status, and Depression in Patients With Acute Leukemia. European Journal of Cancer Care. 2025;2025(1):7989087. doi:10.1155/ecc/7989087
4. Lee YH, Hong J, Kim I, Choi Y, Park HK. Prospective evaluation of clinical symptoms of chemotherapy-induced oral mucositis in adult patients with acute leukemia: A preliminary study. Clinical and Experimental Dental Research. 2020;6(1):90-99. doi:10.1002/cre2.253
5. Stone RM. The difficult problem of acute myeloid leukemia in the older adult. CA Cancer J Clin. 2002;52(6):363-371. doi:10.3322/canjclin.52.6.363
6. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4(4):277-284. doi:10.1038/nrc1318
7. Figliolia SLC, Oliveira DT, Pereira MC, et al. Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Oral Dis. 2008;14(8):761-766. doi:10.1111/j.1601-0825.2008.01468.x
8. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis. 2006;12(3):229-241. doi:10.1111/j.1601-0825.2006.01258.x
9. Elad S, Cheng KKF, Lalla RV, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423-4431. doi:10.1002/cncr.33100